InvestorsHub Logo
Followers 27
Posts 744
Boards Moderated 0
Alias Born 07/12/2012

Re: None

Friday, 07/14/2017 5:25:00 PM

Friday, July 14, 2017 5:25:00 PM

Post# of 346545
No Bavi trials to drain Avid...why spin off?


Interesting. The only PPHM trials now are the 3 NCCN trials - and $1 million of the $2 million fee has already been paid.

As I've mentioned a GAZillion times, the NCCN Bavi-Keytruda Head and Neck trial will be the most important in the company's history.

So why spin off Avid? The argument was that Bavi R&D drains money away from Avid. But this isn't so.

I think it's to appease Ronin. Ronin may have backed itself into a corner by stating Bavi has been a failure, and what really fascinates them is Avid.

Well, Bavi has NOT been a failure.

Ronin sang high praises for Avid in its letter. Well, it looks like they're going to get it.

Before the ASM.

I'm afraid we're going to be stuck with the current BOD for Bavi's development.

Fortunately, the R&D is in MSK and NCCN's hands, not PPHM's.

Probably the best we can hope for. Possibly a compromise for the Board.

Avid revenues get maxed by Ronin's team, while PPHM hands off all research to MSK and NCCN for PS Blockade.

Best,

Joe Six Pack




Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News